Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.

Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.

Item
http://www.wikidata.org/entity/Q40101829
Intensive care medicine research agenda on invasive fungal infection in critically ill patients.A Review of Diagnostic Methods for Invasive Fungal Diseases: Challenges and Perspectives.Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.Is it time to combine untargeted antifungal strategies to reach the goal of 'early' effective treatment?Evaluation of the use of novel biomarkers to augment antimicrobial stewardship program activities.Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.Biomarker-guided antifungal therapy in patients with suspected invasive candidiasis: Ready for prime time?T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications.
P2860

Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.

Item
http://www.wikidata.org/entity/Q40101829
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.
@en
type
label
Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.
@en
prefLabel
Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698